Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine A induced hypertensive nephropathy in dTG mice (original) (raw)

Aliskiren Normalizes Systolic Blood Pressure , Albuminuria , Glomerular Filtration Rate , and Cardiac Hypertrophy in RenTg Mice

Christos Chatziantoniou

View PDFchevron_right

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

Yinong Zhou

View PDFchevron_right

Renoprotective effect of aliskiren monotherapy and aliskiren−pentoxifylline combination in hypertensive-diabetic type 2 patients with diabetic nephropathy

Mohammed Taha

Bulletin of Faculty of Pharmacy, Cairo University, 2013

View PDFchevron_right

Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis

Diana Rubel, Oliver Gross

American journal of hypertension, 2011

View PDFchevron_right

Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury—beyond the direct renin inhibition

Mai-szu Wu

Hypertension Research, 2012

View PDFchevron_right

Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases

Abul Najmi

Journal of Pharmacy and Pharmacology, 2012

View PDFchevron_right

Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study

Erdal Alkan, Emre Karakus

Renal Failure, 2014

View PDFchevron_right

Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats

Nahed Hassanein

Naunyn-Schmiedeberg's Archives of Pharmacology, 2016

View PDFchevron_right

Renoprotective Effects of Combined Aliskiren and Valsartan in Progressive Diabetic Nephropathy in Rats

Dr.Krishna Mohan Chinnala

International Journal of Pharmaceutical Sciences and Nanotechnology, 2011

View PDFchevron_right

Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis

Ramona Nicotera

International Urology and Nephrology, 2015

View PDFchevron_right

Aliskiren in the treatment of renal disease; a narrative review

Bijan Roshan

Journal of Parathyroid Disease

View PDFchevron_right

Direct Renin inhibitor: aliskiren in chronic kidney disease

Yoshiyuki Morishita

Nephro-urology monthly, 2013

View PDFchevron_right

Aliskiren Reduces the Adrenal Zona Glomerulosa Apoptosis and Autophagy in Wistar Rats with 2K1C Hypertension

Jemima Silva

International Journal of Hypertension

View PDFchevron_right

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

Hans-henrik Parving

New England Journal of Medicine, 2008

View PDFchevron_right

Renoprotective Effects Aliskiren on Adenine-induced Tubulointerstitial Nephropathy: Possible Underlying Mechanisms

Hala Malek

Canadian Journal of Physiology and Pharmacology, 2016

View PDFchevron_right

Treatment with aliskiren ameliorates tacrolimus-induced nephrotoxicity in rats

H. Korashy

Journal of the Renin-Angiotensin-Aldosterone System, 2014

View PDFchevron_right

Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats

Sonia Gandhi

Journal of the Renin-Angiotensin-Aldosterone System, 2012

View PDFchevron_right

Protective effects of aliskiren and valsartan in mice with diabetic nephropathy

Jeffrey Kopp

Journal of the renin-angiotensin-aldosterone system : JRAAS, 2014

View PDFchevron_right

Renin Inhibition Reverses Renal Disease in Transgenic Mice by Shifting the Balance Between Profibrotic and Antifibrotic Agents

AHmed ABed

Hypertension, 2013

View PDFchevron_right

The Antihypertensive and Renoprotective Efficacy of Aliskiren: Results of Every Other Day Administration

Rigas Kalaitzidis

Journal of Hypertension, 2011

View PDFchevron_right

Safety of enhanced renin–angiotensin–aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease

Przemysław Rutkowski

Polish Archives of Internal Medicine, 2013

View PDFchevron_right

Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients

P.J. Blankestijn

Nephrology Dialysis Transplantation, 2011

View PDFchevron_right

Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?

Vjekoslav Gerc

Medical Archives, 2009

View PDFchevron_right

Effect of Aliskiren on Renal Cortical Ischemia/Reperfusion Injury in Albino Rats: A Histological and Immunohistochemical Study

Alshaymaa Aboulkhair

Egyptian Journal of Histology

View PDFchevron_right

Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury

Abul Najmi

Journal of the Renin-Angiotensin-Aldosterone System, 2013

View PDFchevron_right

Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans

William Dole

Circulation, 2008

View PDFchevron_right

Aliskiren inhibits experimental venous thrombosis in two-kidney one-clip hypertensive rats

Adam Hermanowicz

Thrombosis research, 2012

View PDFchevron_right

The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study

Chi-bon Leung

PLoS ONE, 2013

View PDFchevron_right

Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney

mohamed essam

Life Sciences, 2021

View PDFchevron_right

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

Hans-henrik Parving

Diabetes Care, 2009

View PDFchevron_right